The page is the record's research on the issuer — no analyst, no rating, no view.

CRESCENT BIOPHARMA, INC. (CBIO) — research page

US · us-cm-kg/NASDAQ/CBIO · as of 2026-11-08

Identity and listing

CRESCENT BIOPHARMA, INC. is listed on NASDAQ under the ticker CBIO. Its ISIN is US38000Q2012 and its LEI is 549300TZ84FFU2J2J459. Its security type is Corporate, its segment is not on the record, its sector is 2834 Pharmaceutical Preparations, and its jurisdiction is the Cayman Islands. Its listing status is listed, not halted.

fieldvaluesource · read date
nameCRESCENT BIOPHARMA, INC.source · 2026-11-08
exchangeNASDAQsource · 2026-11-08
tickerCBIOsource · 2026-11-08
ISINUS38000Q2012source · 2026-11-08
LEI549300TZ84FFU2J2J459source · 2026-11-08
security typeCorporatesource · 2026-11-08
segmentnot on the record
sector2834 Pharmaceutical Preparationssource · 2026-11-08
jurisdictionCayman Islandssource · 2026-11-08
statuslisted, not haltedsource · 2026-11-08

The disclosure read

The record holds 81 filings across 34 filing days in the window 2025-11-08 to 2026-11-08. The median gap between filing days is 8 days. The latest filing is a regulatory filing dated 2026-10-27, 12 days before the record date. The filings comprise 31 directors' dealings, 24 regulatory filings, 11 prospectuses, 8 results, 4 AGM/EGM filings and 3 corporate news items. On NASDAQ the median cadence gap is 6.0 days, the median filing count is 52 and the median latency is 5.0 days. In the sector 2834 Pharmaceutical Preparations, the median cadence gap is 6.0 days, the median filing count is 63.0 and the median latency is 4.0 days.

filingsmedian gap between filing daysdays from latest filing to as-of
this issuer81812
exchange median: NASDAQ (4359 issuers)5265
sector median: 2834 Pharmaceutical Preparations (526 issuers)6364
datetypecategoryfiling
2026-10-27regulatory_filingSCHEDULE 13GSCHEDULE 13G
2026-10-15corporate_news8-K8-K — 8-K (items 8.01)
2026-09-18directors_dealings44 — FORM 4
2026-09-18directors_dealings44 — FORM 4
2026-09-18directors_dealings44 — FORM 4

window 2025-11-08 to 2026-11-08 · the node's disclosure lines, as get_filings serves them

Auditor

The auditor of record is PricewaterhouseCoopers LLP, located in Boston, Massachusetts. The record holds no auditor changes.

Events and halts

The record holds one listing dated 2025-11-06. It holds no delisting, no name change and no segment move. The domicile change is not on the record, as EDGAR states no dated change of state of incorporation on a filing line. The segment move is not on the record, as the exchanges' tier transfers are not EDGAR filings. The halt flag shows listed, not halted.

Orderability

The outcome is not determinable, because the chapter's orderability section carries no client categories and so the outcome cannot name its client category. The rule version is acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, and the chapter is as of 2026-11-04.

rule acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1 · chapter as of 2026-11-04 · the full outcome: get_orderability

Coverage

No research houses were found on the issuer's own investor-relations page.

Open research

No openly published research notes were found on the record.

Licensed

Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.

licensorentitlementtitledatesource
none loaded

As-of depth

The record holds sealed years 2021, 2022, 2023, 2024, 2025 and 2026 for this issuer. The market's earliest sealed date is 2021-01-04, and the live record began on 2026-09-12.

Sources

9 source pages are named on this page; every value above carries its own source page and read date in the numbers.

10.1
https://www.sec.gov/files/company_tickers_exchange.json (identity.exchange)
10.2
https://mapping.gleif.org/api/v2/isin-lei/latest (identity.isin)
10.3
https://data.sec.gov/submissions/CIK0001253689.json (identity.jurisdiction)
10.4
https://mapping.gleif.org/api/v2/isin-lei/latest/download (identity.lei)
10.5
https://mcp.us-cm-kg.ai/events/NASDAQ/CBIO (the disclosure lines)
10.6
https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts (the halt flag)
10.7
https://www.sec.gov/Archives/edgar/data/1253689/000162828026011983/cbio-20251231.htm (the auditor)
10.8
https://mcp.us-cm-kg.ai/book/aio.json (the orderability chapter)
10.9
https://mcp.us-cm-kg.ai/record/NASDAQ/CBIO (the record)

Read it by agent

The same page, signed and receipted: get_research at https://mcp.getresearch.ai/mcp with {"isin":"US38000Q2012"}. Twins: .md · .json. Written: Claude through the platform account, Haiku class; one pass; checked against the numbers. Page hash sha256:df9952efddbdbccd.